MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijid.2025.108119

Медицинская библиотека · International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025

Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention.

Oppong Alexandra E, Coelewij Leda, Hutchinson Matthew, Carpenter Ben, Robinson George A, Liddle Trevor, Hawkins Ellie, Cox Miriam F, Ciurtin Coziana, Venkatachalam Srinivasan, Collin Matthew, Tattersall Rachel S, Ardern-Jones Michael, Duncombe Andrew S, Jury Elizabeth C, Manson Jessica J

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Dexamethasone is recommended for use in all patients with COVID-19 requiring supplemental oxygen, however, only some patients develop hyperinflammation (COV-HI) potentially influencing their response to corticosteroids. This study tested the ability of criteria defining COV-HI to predict response to dexamethasone.

METHODS

A retrospective, multicentre, observational cohort study of 1313-patients with PCR-confirmed COVID-19 during first and second waves of community-acquired infection including 212 patients who received dexamethasone monotherapy. Demographic data, laboratory tests and clinical status were recorded from admission until death or discharge, with minimum 28-days follow-up. Patients were stratified at admission as COV-HI-YES/COV-HI-NO based on three published COV-HI definitions.

RESULTS

Patients with COV-HI shared a biological phenotype of hypoalbuminemia/anemia, and elevated D-dimer/lactate dehydrogenase/alanine transaminase/respiratory rates. Combining these features predicted 28-day mortality and stratified COV-HI-YES from COV-HI-NO more effectively compared to individual markers/demographic features alone. In COV-HI-YES patients, dexamethasone treatment halved mortality-risk (relative risk = 0.50) compared to untreated patients. However, in COV-HI-NO patients mortality-risk was 3.03x higher (CI = 1.3-7.0) in treated versus untreated patients during a 28-day admission period.

CONCLUSIONS

We present a framework for a new machine-learning based scoring system for COV-HI combining clinical assessment with laboratory markers for prediction of mortality and targeting glucocorticoids in hospitalized COVID-19 patients.

Для цитирования: Oppong Alexandra E, Coelewij Leda, Hutchinson Matthew, Carpenter Ben, Robinson George A, Liddle Trevor, Hawkins Ellie, Cox Miriam F, Ciurtin Coziana, Venkatachalam Srinivasan, Collin Matthew, Tattersall Rachel S, Ardern-Jones Michael, Duncombe Andrew S, Jury Elizabeth C, Manson Jessica J. Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2025. DOI: 10.1016/j.ijid.2025.108119.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.